Latest Cancer News

FDA approves new type of therapy to treat advanced urothelial cancer (12-19-2019)
Today, the U.S. Food and Drug Administration granted accelerated approval to Padcev (enfortumab vedotin-ejfv), a Nectin-4-directed antibody and microtubule inhibitor conjugate, meaning the drug specifically... Continue Reading

FDA Grants Accelerated Approval to Brukinsa for Mantle Cell Lymphoma (12-5-2019)
Continued approval may be contingent upon verification of clinical benefit in a confirmatory trial The Food and Drug Administration (FDA) has granted accelerated approval to Brukinsa (zanubrutinib; BeiGene... Continue Reading

Superior Overall Survival for Opdivo (nivolumab) Plus Low-Dose Yervoy (ipilimumab) compared Chemotherapy in Advanced Non-Small Cell Lung Cancer (11-29-2019)
The Opdivo plus low-dose Yervoy immunotherapy combination improved long-term survival for patients with advanced non-small cell lung cancer (NSCLCC) across PD-L1 expression levels. (3) Both Opdivo and... Continue Reading

More Cancer News

Locations

Jackson
322 Hospital Boulevard
Jackson, TN 38305
731-668-1668
800-870-5471
Dyersburg
440 Wilkinson Drive
Dyersburg, TN 38024
731 285-2211
888-748-8511
Paris
1290 Kelley Drive
Paris, TN 38242
731-644-3522
800-221-0948